Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer.

Youngjin KangSeung-Eun LeeChul Hwan Kim Chung Gyo Seo

Published in: Translational lung cancer research (2024)

PD-L1 expression in NSCLC is associated with adverse clinicopathological features and recurrence; therefore, it could be utilized to predict poor prognosis. Furthermore, the high PD-L1 expression of SP142 in tumor-infiltrating ICs could be a potential marker for low metastasis.

Keyphrases

poor prognosis
long non coding rna
small cell lung cancer
advanced non small cell lung cancer
free survival
emergency department
adverse drug
risk assessment
epidermal growth factor receptor